Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists

Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists

US Patent 6528522 · Granted Mar 4, 2003

Estimated economic value: $114,512,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PAPD5 inhibitors and methods of use thereof2025
Substituted heterocycles as aldehyde dehydrogenase inhibitors2024
Compounds and their use for reducing uric acid levels2021
Compounds and their use for reducing uric acid levels2021
Compounds and their use for reducing uric acid levels2021
Compounds and their use for reducing uric acid levels2020
Compounds and their use for reducing uric acid levels2020
Aminopyrazine compounds with A2A antagonist properties2020
Compounds and their use for reducing uric acid levels2020
Pyridone derivative comprising heteroatomic ring butane substituent, for treatin2020
Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-ph2019
Bifunctional compounds and use for reducing uric acid levels2018